PS1-44: Reviewing Electronic Medical Records of Patients Assessed for Polycythemia Vera by a Multiphysician/Multicenter Group Practice Can Both Identify Physician Errors and Lead to Targeted Medical Education.

Background/Aims In 2005, researchers described an acquired mutation in JAK-STAT signaling, the JAK2V617F mutation which is present in 95% of patients with P. vera (PV). Within three years, testing for this mutation led to new World Health Organization (WHO) criteria for the diagnosis of PV, and other related myeloproliferative neoplasms. This project was initiated to assess the impact of molecular testing within a multiphysician, multicenter group practice and ultimately to use this knowledge to develop educational programs regarding how best to evaluate patients with polycythemia.